Expression of the immune checkpoint modulator OX40 indicates poor survival in acute myeloid leukemia

Marconato, Maddalena; Kauer, Joseph; Salih, Helmut R. R.; Maerklin, Melanie; Heitmann, Jonas S. S.

dc.contributor.author	Marconato, Maddalena
dc.contributor.author	Kauer, Joseph
dc.contributor.author	Salih, Helmut R.
dc.contributor.author	Märklin, Melanie
dc.contributor.author	Heitmann, Jonas S.
dc.date.accessioned	2023-12-12T07:24:35Z
dc.date.available	2023-12-12T07:24:35Z
dc.date.issued	2022
dc.identifier.issn	2045-2322
dc.identifier.uri	http://hdl.handle.net/10900/148637
dc.language.iso	en	de_DE
dc.publisher	Berlin : Nature Portfolio	de_DE
dc.relation.uri	http://dx.doi.org/10.1038/s41598-022-19972-1	de_DE
dc.subject.ddc	500	de_DE
dc.title	Expression of the immune checkpoint modulator OX40 indicates poor survival in acute myeloid leukemia	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230925000000_01559
utue.personen.roh	Marconato, Maddalena
utue.personen.roh	Kauer, Joseph
utue.personen.roh	Salih, Helmut R. R.
utue.personen.roh	Maerklin, Melanie
utue.personen.roh	Heitmann, Jonas S. S.
dcterms.isPartOf.ZSTitelID	Scientific Reports	de_DE
dcterms.isPartOf.ZS-Issue	Article 15856	de_DE
dcterms.isPartOf.ZS-Volume	12 (1)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE